299 related articles for article (PubMed ID: 30644496)
1. Microfluidic modelling of the tumor microenvironment for anti-cancer drug development.
Shang M; Soon RH; Lim CT; Khoo BL; Han J
Lab Chip; 2019 Jan; 19(3):369-386. PubMed ID: 30644496
[TBL] [Abstract][Full Text] [Related]
2. Multiwell capillarity-based microfluidic device for the study of 3D tumour tissue-2D endothelium interactions and drug screening in co-culture models.
Virumbrales-Muñoz M; Ayuso JM; Olave M; Monge R; de Miguel D; Martínez-Lostao L; Le Gac S; Doblare M; Ochoa I; Fernandez LJ
Sci Rep; 2017 Sep; 7(1):11998. PubMed ID: 28931839
[TBL] [Abstract][Full Text] [Related]
3. Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.
Agarwal P; Wang H; Sun M; Xu J; Zhao S; Liu Z; Gooch KJ; Zhao Y; Lu X; He X
ACS Nano; 2017 Jul; 11(7):6691-6702. PubMed ID: 28614653
[TBL] [Abstract][Full Text] [Related]
4. A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy.
Pradhan S; Smith AM; Garson CJ; Hassani I; Seeto WJ; Pant K; Arnold RD; Prabhakarpandian B; Lipke EA
Sci Rep; 2018 Feb; 8(1):3171. PubMed ID: 29453454
[TBL] [Abstract][Full Text] [Related]
5. Identification of drugs as single agents or in combination to prevent carcinoma dissemination in a microfluidic 3D environment.
Bai J; Tu TY; Kim C; Thiery JP; Kamm RD
Oncotarget; 2015 Nov; 6(34):36603-14. PubMed ID: 26474384
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional culture models to study drug resistance in breast cancer.
Fisher MF; Rao SS
Biotechnol Bioeng; 2020 Jul; 117(7):2262-2278. PubMed ID: 32297971
[TBL] [Abstract][Full Text] [Related]
7. High-throughput analysis of cell-cell crosstalk in ad hoc designed microfluidic chips for oncoimmunology applications.
Mencattini A; De Ninno A; Mancini J; Businaro L; Martinelli E; Schiavoni G; Mattei F
Methods Enzymol; 2020; 632():479-502. PubMed ID: 32000911
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiologically relevant in vitro tumor models for drug screening.
Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
[TBL] [Abstract][Full Text] [Related]
9. Applications of tumor chip technology.
Hachey SJ; Hughes CCW
Lab Chip; 2018 Sep; 18(19):2893-2912. PubMed ID: 30156248
[TBL] [Abstract][Full Text] [Related]
10. Real-time and non-invasive impedimetric monitoring of cell proliferation and chemosensitivity in a perfusion 3D cell culture microfluidic chip.
Lei KF; Wu MH; Hsu CW; Chen YD
Biosens Bioelectron; 2014 Jan; 51():16-21. PubMed ID: 23920091
[TBL] [Abstract][Full Text] [Related]
11. Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment.
Niu Y; Bai J; Kamm RD; Wang Y; Wang C
Mol Pharm; 2014 Jul; 11(7):2022-9. PubMed ID: 24533867
[TBL] [Abstract][Full Text] [Related]
12. Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids.
Shirure VS; Bi Y; Curtis MB; Lezia A; Goedegebuure MM; Goedegebuure SP; Aft R; Fields RC; George SC
Lab Chip; 2018 Dec; 18(23):3687-3702. PubMed ID: 30393802
[TBL] [Abstract][Full Text] [Related]
13. Mimicking Tumors: Toward More Predictive In Vitro Models for Peptide- and Protein-Conjugated Drugs.
van den Brand D; Massuger LF; Brock R; Verdurmen WP
Bioconjug Chem; 2017 Mar; 28(3):846-856. PubMed ID: 28122451
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic-enabled self-organized tumor model for in vitro cytotoxicity assessment of doxorubicin.
Yang Y; Liu S; Chen C; Huang H; Tao L; Qian Z; Li W
Biomed Microdevices; 2020 Sep; 22(4):70. PubMed ID: 32960346
[TBL] [Abstract][Full Text] [Related]
15. 3D modeling in cancer studies.
Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
[TBL] [Abstract][Full Text] [Related]
16. Probing characteristics of cancer cells cultured on engineered platforms simulating different microenvironments.
Jo Y; Choi N; Kim HN; Choi J
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1170-1179. PubMed ID: 29519165
[TBL] [Abstract][Full Text] [Related]
17. Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.
Han B; Qu C; Park K; Konieczny SF; Korc M
Cancer Lett; 2016 Sep; 380(1):319-29. PubMed ID: 26688098
[TBL] [Abstract][Full Text] [Related]
18. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.
Li W; Zhou Z; Zhou X; Khoo BL; Gunawan R; Chin YR; Zhang L; Yi C; Guan X; Yang M
Adv Healthc Mater; 2023 Jul; 12(18):e2202609. PubMed ID: 36917657
[TBL] [Abstract][Full Text] [Related]
19. Nanofiber membrane supported lung-on-a-chip microdevice for anti-cancer drug testing.
Yang X; Li K; Zhang X; Liu C; Guo B; Wen W; Gao X
Lab Chip; 2018 Jan; 18(3):486-495. PubMed ID: 29309077
[TBL] [Abstract][Full Text] [Related]
20. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
